High density lipoproteins and reverse cholesterol transport: Lessons from mutations

Atherosclerosis

Volumn 137, Issue SUPPL., 1998, Pages

  Von Eckardstein, Arnold ^a,b   Assmann, Gerd ^a  

^a Inst fur Arterioskleroseforschung   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Apo A I; Apo A IV; Apo E; HDL deficiency; HDL subclasses; Macrophage; Tangier disease; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN;

CHOLESTEROL TRANSPORT; CONFERENCE PAPER; ELECTROPHORETIC MOBILITY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; LIPOPROTEIN METABOLISM; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANGIER DISEASE; TRANSGENIC MOUSE;

ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; BIOLOGICAL TRANSPORT, ACTIVE; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; MUTATION; TANGIER DISEASE;

EID: 0031777005     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00311-0     Document Type: Conference Paper

References (56)

1. Fielding C, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995;36:211-28.
2. von Eckardstein A. Cholesterol efflux from macrophages and other cells. Curr Opin Lipidol 1996;7:308-19.
3. Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phopsholipids. J Lipid Res 1997;37:2473-91.
4. von Eckardstein A, Huang Y, Assmann G. Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol 1994;5:404-16.
5. Barrans A, Jaspard B, Barbaras R, Chap H, Perret B, Collet X. Pre-β HDL: structure and metabolism. Biochim Biophys Acta 1996;1300:73-83.
6. Castro GR, Fielding CJ. Early incorporation of cell-derived cholesterol into pre-β-migrating high density lipoprotein. Biochemistry 1988;27:25-9.
7. Huang Y, von Eckardstein A, Wu S, Maeda N, Assmann G. A solely apolipoprotein E containing plasma lipoprotein with electrophoretic γ-mobility takes up cellular cholesterol. Proc Natl Acad Sci USA 1994;91:1834-8.
8. von Eckardstein A, Huang Y, Wu S, SaadatSarmadi A, Schwarz S, Steinmetz A, Assmann G. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma. Arterioscler Thromb Vasc Biol 1995;15:1755-63.
9. Kawano M, Miida T, Fielding CJ, Fielding PE. Quantitation of preβ-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid. Biochemistry 1993;32:5025-8.
10. Czarnecka H, Yokoyama S. Regulation of cellular cholesterol efflux by lecithin: cholesterol acyltransferase reaction through nonspecific lipid exchange. J Biol Chem 1996;266:2023-8.
11. Czarnecka H, Yokoyama S. Lecithin: cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux. Biochemistry 1995;34:4385-92.
12. Hara H, Yokoyama S. Interaction of free apolipoproteins with macrophages: formation of high density lipoprotein-like lipoproteins and reduction of cellular cholesterol. J Biol Chem 1991;266:3080-6.
13. Yancey PG, Bielicki JK, Johnson WJ, Lund-Katz S, Palgunachari MN, Anantharamaiah GM, Segrest JP, Phillips MC, Rothblat GH. Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides. Biochemistry 1995;34:7955-65.
14. Li Q, Yokoyama S. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J Biol Chem 1995;269:26216-23.
15. Francis GA, Knopp RH, Oram JF. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 1995;96:78-87.
16. Mendez AJ, Oram JF, Bierman EL. Protein kinase C as a mediator of high density lipoprotein dependent efflux of intracellular cholesterol. J Biol Chem 1991;266:10104-11.
17. von Eckardstein A, Huang Y, Wu S, Noseda G, Assmann G. Reverse cholesterol transport in plasma of patients with different forms of familial high density lipoprotein deficiency. Arterioscler Thromb Vasc Biol 1995;15:690-701.
18. Assmann G, von Eckardstein A, Brewer HB Jr, Familial high density lipoprotein deficiency: Tangier disease. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The Metabolic Basis of Inherited Disease, 7th ed. New York: McGraw-Hill, 1995:2053-2072.
19. Pisa - causes high density lipoprotein deficiency corneal opacifications and coronary heart disease. Circulation 1996;94:1622-8.
20. Pisa - interferes with the formation of α-high density lipoproteins (HDL) but not with the formation of prebeta1-HDL: effects on cholesterol efflux into plasma. J Lipid Res 1997;38:1242-53.
21. 1-HDL conversion in Tangier disease. Arterioscler Thromb Vasc Biol 1995;15:1746-54.
22. Asztalos BF, Sloop CH, Wong L, Roheim PS. Comparison of apo A-I-containing subpopulations of dog plasma and prenodal peripheral lymph: evidence for alteration in subpopulations in the interstitial space. Biochim Biophys Acta 1993;1169:301-4.
23. Jaspard B, Collet X, Barbaras R, Manent J, Vieu C, Pontonnier G, Chap H, Perret B. Biochemical characterization of preβ1-high-density lipoprotein from human ovarian follicular fluid: evidence for the presence of a lipid core. Biochemistry 1996;35:1352-7.
24. Clay MA, Newnham HH, Forte TM, Barter PJ. Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochim Biophys Acta 1992;1124:52-8.
25. Hennessy LK, Kunitake ST, Kane JP. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II as progenitors of preβ-high density lipoprotein particles. Biochemistry 1993;32:5759-65.
26. Francone OL, Royer L, Haghpassand M. Increased preβ-HDL levels cholesterol efflux and LCAT mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apo A-I) transgenes. J Lipid Res 1996;37:1268-77.
27. 1-HDL. Biochim Biophys Acta 1996;1301:255-61.
28. Jiang X-J, Francone OL, Bruce C, Milne R, Mar J, Walsh A, Breslow JL, Tall AR. Increased preβ-high density lipoprotein apolipoprotein A-I and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein A-I transgenes. J Clin Invest 1996;98:2373-80.
29. Barrans A, Collet X, Barbaras R, Jaspard B, Manent J, Vieu C, Chap H, Perret B. Hepatic lipase induces the formation of preβ1-high-density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem 1994;269:11572-7.
30. Ishida BY, Albee D, Paigen B. Interconversion of prebeta migrating lipoproteins containing apo A-I and HDL. J Lipid Res 1990;31:227-36.
31. Neary R, Bhatnagar D, Durrington P, Ishola M, Arrol S, Mackness M. An investigation of the role of lecithin: cholesterol acyltransferase.and triglyceride-rich lipoproteins in the metabolism of high density lipoproteins. Atherosclerosis 1991;89:35-48.
32. Miida T, Kawano M, Fielding CJ, Fielding PE. Regulation of the concentration of preβ-high-density lipoprotein in normal plasma by cell membranes and lecithin:cholesterol acyltransferase. Biochemistry 1992;31:11112-7.
33. Liang H-Q, Rye K-A, Barter PJ. Remodelling of reconstituted high density lipoproteins by lecithin: cholesterol acyltransferase. J Lipid Res 1996;37:1962-70.
34. Clay MA, Barter PJ. Formation of new HDL particles from lipid-free apolipoprotein A-I. J Lipid Res 1996;37:1722-32.
35. Musliner TA, Long DL, Forte TM, Nichols AV, Gong EL, Blanche Krauss RM. Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I. J Lipid Res 1991;32:917-32.
36. Kunitake ST, Mendel CM, Hennessy LK. Interconversion between apolipoproteins of preβ and α electrophoretic mobilities. J Lipid Res 1992;33:1807-16.
37. Liang H-Q, Rye K-A, Barter PJ. Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools. Biochim Biophys Acta 1995;1257:31-7.
38. Fielding CJ, Moser A. Evidence for the separation of albumin- and apo A-I-dependent mechanisms of cholesterol efflux from cultured fibroblasts into human plasma. J Biol Chem 1982;257:10955-10960.
39. Zhao Y, Marcel YL. Serum albumin is a significant intermediate in cholesterol transfer between cells and lipoproteins. Biochemistry 1996;35:7174-80.
40. Huang Y, von Eckardstein A, Wu S, Assmann G. Effects of the apolipoprotein E-polymorphism on uptake and transfer of cell-derived cholesterol in plasma. J Clin Invest 1995;96:2693-701.
41. Krimbou JL, Tremblay M, Davignon J, Cohn JS. Characterization of human plasma apolipoprotein E containing lipoproteins in the high density lipoprotein size range: focus on preβ1-LpE, preβ2-LpE and α-LpE. J Lipid Res 1997;38:35-48.
42. Duverger N, Ghalim N, Ailhaud G, Steinmetz A, Fruchart J-C, Castro G. Characterization of apo A-IV-containing lipoprotein particles isolated form human plasma and interstitial fluid. Arterioscler Thromb 1993;13:126-32.
43. von Eckardstein A, Zhu A, Bellosta S, Bernini F, Hoffmann M, März W, Assmann G. Defective cholesterol efflux into plasmas of apolipoprotein E-deficient men and mice. Eur J Clin Chem Clin Biochem (abstract) 1997;35:1732.
44. Huang Y, Langer C, Raabe M, Wiesenhütter B, Wu S, Seedorf U, Maeda N, Assmann G, von Eckardstein A. Effects of geno-type and diet on cholesterol efflux into plasma and lipoproteins of normal, apolipoprotein A-I- and apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1997;17:2010-9.
45. Bellosta S, Mahley RW, Sanan DA, Newland DL, Taylor JM, Pitas RE. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J Clin Invest 1995;96:2170-9.
46. von Eckardstein A, Bellosta S, Zhu Y, Bernini F, Pitas RE, Assmann G. Macrophage specific expression of human apolipoprotein E in apolipoprotein E deficient mice increases cholesterol efflux and esterification capacities of plasma. Circulation (abstract) 1997;96(Suppl 1):1934.
47. Mazzone T. Apolipoprotein E secretion by macrophages: its potentil functions. Curr Opin Lipidology 1996;7:303-10.
48. Basu SK, Ho Y, Brown MS, Bilheimer DW, Anderson RGW, Goldstein J. Biochemical and genetic studies of the apoprotein E secreted by mouse macrophages and human monocytes. J Biol Chem 1982;257:9788-95.
49. Basu S, Goldstein JL, Brown MS. Independent pathways for secretion of free cholesterol and apolipoprotein E by macrophages. Science 1983;219:871-3.
50. Dory L. Synthesis and secretion of apo E in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux. J Lipid Res 1989;30:809-16.
51. 3. J Lipid Res 1994;35:1345-53.
52. Kruth HS, Skarlatos SI, Gaynor PM, Gamble W. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux. J Biol Chem 1994;269:24511-8.
53. Hayek T, Oiknine J, Brook JG, Aviram M. Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knock out transgenic mice. Biochem Biophys Res Commun 1994;205:1072-8.
54. Zhang WY, Gaynor PM, Kruth HS. Apolipoprotein E produced by human monocyte-derived macrophages mediates cholesterol efflux that occurs in the absence of added cholesterol acceptors. J Biol Chem 1996;271:28641-6.
55. Cullen P, Cignarella A, von Eckardstein A, Mohr S, Assmann G. Phenotype-dependent differences in apolipoprotein E gene expression and protein secretion in human monocyte-derived macrophages. Circulation 1996;94:1-273.
56. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Gleaves LA, Atkinson JB, Linton MF. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci USA 1997;94:4647-52.